Conmed Corp (CNMD)
71.31
-1.30
(-1.79%)
USD |
NYSE |
Apr 23, 16:00
71.31
0.00 (0.00%)
After-Hours: 18:23
Conmed SG&A Expense (Quarterly): 117.96M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 117.96M |
September 30, 2023 | 125.30M |
June 30, 2023 | 129.70M |
March 31, 2023 | 130.08M |
December 31, 2022 | 120.74M |
September 30, 2022 | 114.60M |
June 30, 2022 | 115.83M |
March 31, 2022 | 102.88M |
December 31, 2021 | 107.28M |
September 30, 2021 | 104.74M |
June 30, 2021 | 104.40M |
March 31, 2021 | 98.34M |
December 31, 2020 | 99.10M |
September 30, 2020 | 94.38M |
June 30, 2020 | 84.48M |
March 31, 2020 | 95.87M |
December 31, 2019 | 102.00M |
September 30, 2019 | 98.19M |
June 30, 2019 | 100.73M |
March 31, 2019 | 99.23M |
December 31, 2018 | 96.46M |
September 30, 2018 | 84.98M |
June 30, 2018 | 89.60M |
March 31, 2018 | 84.57M |
December 31, 2017 | 92.40M |
Date | Value |
---|---|
September 30, 2017 | 80.81M |
June 30, 2017 | 83.83M |
March 31, 2017 | 94.76M |
December 31, 2016 | 86.72M |
September 30, 2016 | 79.01M |
June 30, 2016 | 86.73M |
March 31, 2016 | 85.94M |
December 31, 2015 | 82.67M |
September 30, 2015 | 72.06M |
June 30, 2015 | 73.58M |
March 31, 2015 | 74.79M |
December 31, 2014 | 79.84M |
September 30, 2014 | 87.06M |
June 30, 2014 | 78.23M |
March 31, 2014 | 78.36M |
December 31, 2013 | 101.70M |
September 30, 2013 | 73.48M |
June 30, 2013 | 77.17M |
March 31, 2013 | 77.72M |
December 31, 2012 | 79.89M |
September 30, 2012 | 74.06M |
June 30, 2012 | 73.71M |
March 31, 2012 | 74.81M |
December 31, 2011 | 69.53M |
September 30, 2011 | 68.35M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
84.48M
Minimum
Jun 2020
130.08M
Maximum
Mar 2023
107.71M
Average
104.40M
Median
Jun 2021
SG&A Expense (Quarterly) Benchmarks
Inspire Medical Systems Inc | 124.10M |
SI-BONE Inc | 37.02M |
Inari Medical Inc | 101.49M |
Electromed Inc | 8.175M |
Myomo Inc | 4.66M |